Only few reports on the prognostic significance of telomerase activity in h
uman cancer exist. To find a new prognostic marker in soft tissue tumors, w
e investigated 60 soft tissue sarcomas of different histology and six benig
n tumors for telomerase activity. Telomerase activity was measured by using
the non-radioactive PCR-based TRAP-assay. PCR products were analyzed on an
automated fluorescence sequencer. Tumors of grade-II and grade-III histolo
gy showed a significantly poorer prognosis. Both disease-free (p<0.03) and
the overall survival (p<0.02) were reduced in the highly malignant sarcoma
patients. We found telomerase activity in 38.3% of the cases, there being a
correlation with a more aggressive behavior of soft tissue sarcomas. Telom
erase activity correlated with the grade of malignancy (p=0.04), but not wi
th sex (p=0.64) or age (p=0.48) of the patients. The total survival was sig
nificantly reduced in patients with telomerase-positive sarcomas (p=0.04).
Both of the patients having grade I tumors with telomerase activity died of
disease, whereas 10 of 11 patients with telomerase-negative grade I tumors
are still alive. Only one of the benign tumors showed telomerase activity.
We suggest that telomerase activity is a potential prognostic factor in ma
lignant soft tissue tumors. Despite the histological heterogeneity of soft
tissue tumors, single entities should be assessed for telomerase activity.